Cochrane · systematic review · CD004733
Prophylactic oral betamimetics for reducing preterm birth in women with a twin pregnancy
Yamasmit, W, Chaithongwongwatthana, S, Tolosa, JE, et al. · Cochrane Database of Systematic Reviews · 2015 · Cochrane Library
Pregnancy and ChildbirthAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
4
current version
GRADE rated
4
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 4 · 100%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Oral betamimetic versus placebo for pregnant women with a twin pregnancy to prevent preterm birth
Population: pregnant women with a twin pregnancy
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Preterm labour Oral betamimetic vs placebo | RR 0.37 [0.17, 0.78] | 2 studies · 194 participants | Low Downgraded: risk of bias, imprecision |
Prelabour rupture of membranes Oral betamimetic vs placebo | RR 1.42 [0.42, 4.82] | 1 study · 144 participants | Low Downgraded: imprecision |
Preterm birth (less than 37 weeks' gestation) Oral betamimetic vs placebo | RR 0.85 [0.65, 1.1] | 4 studies · 276 participants | Low Downgraded: imprecision |
Very preterm birth (less than 34 weeks' gestation) Oral betamimetic vs placebo | RR 0.47 [0.15, 1.5] | 1 study · 144 participants | Low Downgraded: imprecision |